Literature DB >> 23218021

Assessment of skin test with varicella-zoster virus antigen for predicting the risk of herpes zoster.

Y Okuno1, Y Takao, Y Miyazaki, F Ohnishi, M Okeda, S Yano, H Kumihashi, Y Gomi, K Maeda, T Ishikawa, Y Mori, H Asada, H Iso, K Yamanishi.   

Abstract

The Shozu Herpes Zoster (SHEZ) Study was designed to clarify the incidence of and predictive and immunological factors for herpes zoster in a defined community-based Japanese population. As part of this series, a total of 5683 residents aged ≥50 years received a varicella-zoster virus (VZV) skin test with VZV antigen, and 48 h later, the erythema and oedema were assessed by measuring the longest diameter. The diameters of both the erythema and oedema decreased with the increasing age of the subject. Sixty-three subjects contracted herpes zoster within a year after receiving the VZV skin test. Analysis of the herpes zoster incidence rate vs. the skin test reaction revealed that the shorter the diameter of erythema or oedema, the greater the likelihood of herpes zoster. These results demonstrated that the VZV skin test is an excellent surrogate marker for predicting the risk of herpes zoster.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23218021      PMCID: PMC9151859          DOI: 10.1017/S0950268812002671

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  24 in total

1.  Enhancement of immunity against VZV by giving live varicella vaccine to the elderly assessed by VZV skin test and IAHA, gpELISA antibody assay.

Authors:  Michiaki Takahashi; Shintaro Okada; Hiromi Miyagawa; Kiyoko Amo; Kunihiko Yoshikawa; Hideo Asada; Hitoshi Kamiya; Sadayoshi Torigoe; Yoshizo Asano; Takao Ozaki; Kibhei Terada; Ryoichi Muraki; Kazbuo Higa; Hiroshi Iwasaki; Masataka Akiyama; Akihisa Takamizawa; Kimibyasu Shiraki; Kazuo Yanagi; Koichi Yamanishi
Journal:  Vaccine       Date:  2003-09-08       Impact factor: 3.641

2.  THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS.

Authors:  R E HOPE-SIMPSON
Journal:  Proc R Soc Med       Date:  1965-01

3.  Antibody response determined with antibody-dependent cell-mediated cytotoxicity (ADCC), neutralizing antibody, and varicella skin test in children with natural varicella and after varicella immunization.

Authors:  T Ihara; T Kato; S Torigoe; K Oitani; M Isaji; M Ito; H Kamiya; M Sakura
Journal:  Acta Paediatr Jpn       Date:  1991-02

4.  Diagnostic skin test reactions with varicella virus antigen and clinical application of the test.

Authors:  H Kamiya; T Ihara; A Hattori; T Iwasa; M Sakurai; T Izawa; A Yamada; M Takahashi
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

Review 5.  Herpes zoster in older adults.

Authors:  K Schmader
Journal:  Clin Infect Dis       Date:  2001-04-17       Impact factor: 9.079

Review 6.  Immunization of the elderly to boost immunity against varicella-zoster virus (VZV) as assessed by VZV skin test reaction.

Authors:  M Takahashi; H Kamiya; Y Asano; K Shiraki; K Baba; T Otsuka; T Hirota; K Yamanishi
Journal:  Arch Virol Suppl       Date:  2001

7.  Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect.

Authors:  M J Levin; D Barber; E Goldblatt; M Jones; B LaFleur; C Chan; D Stinson; G O Zerbe; A R Hayward
Journal:  J Infect Dis       Date:  1998-11       Impact factor: 5.226

8.  Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine.

Authors:  M J Levin; M N Oxman; J H Zhang; G R Johnson; H Stanley; A R Hayward; M J Caulfield; M R Irwin; J G Smith; J Clair; I S F Chan; H Williams; R Harbecke; R Marchese; S E Straus; A Gershon; A Weinberg
Journal:  J Infect Dis       Date:  2008-03-15       Impact factor: 5.226

9.  Superiority of varicella skin test antigen over purified varicella-zoster virus glycoproteins in monitoring booster response to Oka varicella vaccine.

Authors:  Hitoshi Sato; Jun ichi Yamamura; Seiji Kageyama; Masahiko Kurokawa; Kimiyasu Shiraki
Journal:  Vaccine       Date:  2003-12-08       Impact factor: 3.641

10.  The Shozu Herpes Zoster (SHEZ) study: rationale, design, and description of a prospective cohort study.

Authors:  Yukiko Takao; Yoshiyuki Miyazaki; Fumitake Onishi; Hideaki Kumihashi; Yasuyuki Gomi; Toyokazu Ishikawa; Yoshinobu Okuno; Yasuko Mori; Hideo Asada; Koichi Yamanishi; Hiroyasu Iso
Journal:  J Epidemiol       Date:  2012-02-18       Impact factor: 3.211

View more
  3 in total

1.  Incidences of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged 50 Years and Older From a Community-based Prospective Cohort Study: The SHEZ Study.

Authors:  Yukiko Takao; Yoshiyuki Miyazaki; Masayuki Okeda; Fumitake Onishi; Shuichiro Yano; Yasuyuki Gomi; Toyokazu Ishikawa; Yoshinobu Okuno; Yasuko Mori; Hideo Asada; Koichi Yamanishi; Hiroyasu Iso
Journal:  J Epidemiol       Date:  2015-09-19       Impact factor: 3.211

2.  Definition and management of varicella zoster virus-associated meningoradiculitis: a case report.

Authors:  Vincent Luisier; Lalensia Weber; Daniel Fishman; Gérard Praz; Joseph-André Ghika; Didier Genoud; Joelle Nsimire Chabwine
Journal:  BMC Res Notes       Date:  2016-09-26

3.  Impact of Zostavax Vaccination on T-Cell Accumulation and Cutaneous Gene Expression in the Skin of Older Humans After Varicella Zoster Virus Antigen-Specific Challenge.

Authors:  Neil P Patel; Milica Vukmanovic-Stejic; Mayte Suarez-Farinas; Emma S Chambers; Daisy Sandhu; Judilyn Fuentes-Duculan; Neil A Mabbott; Malcolm H A Rustin; James Krueger; Arne N Akbar
Journal:  J Infect Dis       Date:  2018-09-22       Impact factor: 5.226

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.